The following tables describe changes to the AHFS Pharmacologic-Therapeutic Classification© that will be published in the 2021 edition of AHFS Drug Information® (February 1, 2021), as well as any new classes added after the publication of the 2020 edition. This is only a partial listing of the AHFS PTC. The full classification system, along with a list of drugs covered in AHFS DI and their corresponding classes, is available in the printed edition and is available electronically in a separate file. Reproduction, storage on a retrieval system, or transmission of this material or any part thereof in any form or by any means without the express written permission of the American Society of Health-System Pharmacists is prohibited.
Please contact ASHP eHealth Solutions Division at +1 (301) 664-8860 for more detailed information.
Drug Assignments
| wdt_ID | Drug Name | Active Ingredients | Company | Indication | Approval Date | AHFS Class | NDA Type | Appl No |
|---|---|---|---|---|---|---|---|---|
| 1 | Skyla® | levonorgestrel | Bayer | birth control | 01/09/2013 | 68:12 - Contraceptives | 5 | 203159 |
| 2 | Uceris® | budesonide extended-release tablets | Santarus | ulcerative colitis | 01/14/2013 | 68:04 - Adrenals | 5S | 203634 |
| 3 | Zecuity® | sumatriptan | Nupathe | migraine headache | 01/17/2013 | 28:32.28 - Selective Serotonin Agonists | 3 | 202278 |
| 4 | Nesina® | alogliptin | Takeda | type 2 diabetes mellitus | 01/25/2013 | 68:20.05 - DPP-4 Inhibitors | 1 | 022271 |
| 5 | Oseni® | alogliptin; pioglitazone | Takeda | type 2 diabetes mellitus | 01/25/2013 | 68:20.05 - DPP-4 Inhibitors; 68:20.28 - Thiazolidinediones | 1 | 022426 |
| 6 | Kazano® | alogliptin; metformin | Takeda | type 2 diabetes mellitus | 01/25/2013 | 68:20.05 - DPP-4 Inhibitors; 68:20.04 - Biguanides | 1 | 203414 |
| 7 | Kynamro® | mipomersen | Genzyme | homozygous familial hyper-cholesterolemia (HoFH) | 01/29/2013 | 24:06.92 - Antilipemic Agents, Miscellaneous | 1 | 203568 |
| 8 | Ravicti® | glycerol phenylbutyrate | Hyperion | urea cycle disorders (UCD) | 02/01/2013 | 40:10 - Ammonia Detoxicants | 2S/O | 203284 |
| 9 | Delzicol® | mesalamine | Warner Chilcott | ulcerative colitis | 02/01/2013 | 56:36 - Anti-inflammatory Agents | 3S | 204412 |
| 10 | Versacloz® | clozapine | Douglas | schizophrenia | 02/06/2013 | 28:16.08.04 - Atypical Antipsychotics | 3 | 203479 |
| Drug Name | Active Ingredients | Company | Indication | Approval Date | AHFS Class | NDA Type | Appl No |
Drug Reassignments
| wdt_ID | Drug Name | Active Ingredients | Change Date | Old AHFS Class | New AHFS Class |
|---|---|---|---|---|---|
| 1 | Adipex®, Ionamin® | phentermine | 01/01/2013 | 28:20.92 | 28:20.08.04 |
| 2 | Adipost®, Bontril® | phendimetrazine | 01/01/2013 | 28:20.92 | 28:20.08.04 |
| 3 | Amoply® | ammonia spirit, aromatic | 01/01/2013 | 28:20.92 | 28:20.32 |
| 4 | Belviq® | lorcaserin | 01/01/2013 | 28:20.92 | 28:20.08.32 |
| 5 | Cafcit®, No Doz®, Vivarin® | caffeine/ caffeine and sodium benzoate | 01/01/2013 | 28:20.92 | 28:20.32 |
| 6 | Concerta®, Daytrana®, Metadate®, Methylin®, Ritalin® | methylphenidate | 01/01/2013 | 28:20.92 | 28:20.32 |
| 7 | Dopram® | doxapram | 01/01/2013 | 28:20.92 | 28:20.32 |
| 8 | Focalin® | dexmethylphenidate | 01/01/2013 | 28:20.92 | 28:20.32 |
| 9 | Kalydeco® | ivacaftor | 01/01/2013 | 48:92 | 48:14.12 |
| 10 | Nuvigil® | armodafinil | 01/01/2013 | 28:20.92 | 28:20.80 |
| Drug Name | Active Ingredients | Change Date | Old AHFS Class | New AHFS Class |
AHFS Class Changes
| wdt_ID | AHFS Class | Change Date | Change Description |
|---|---|---|---|
| 1 | 28:20 - Anorexigenic Agents and Respiratory and CNS Stimulants | 01/01/2013 | Name Change |
| 2 | 28:20.08 - Anorexigenic Agents | 01/01/2013 | New classification |
| 3 | 28:20.08.04 - Amphetamine Derivatives | 01/01/2013 | New classification |
| 4 | 28:20.08.32 - Selective Serotonin Receptor Agonists | 01/01/2013 | New classification |
| 5 | 28:20.32 - Respiratory and CNS Stimulants | 01/01/2013 | New classification |
| 6 | 28:20.80 - Wakefulness-promoting Agents | 01/01/2013 | New classification |
| 7 | 28:20.92 - Anorexigenic Agents and Stimulants, Miscellaneous | 01/01/2013 | Name Change |
| 8 | 48:14 - Cystic Fibrosis Transmembrane Conductance Regulator Modulators | 01/01/2013 | New classification |
| 9 | 48:14.04 - Cystic Fibrosis Transmembrane Conductance Regulator Correctors | 01/01/2013 | New classification |
| 10 | 48:14.12 - Cystic Fibrosis Transmembrane Conductance Regulator Potentiators | 01/01/2013 | New classification |
| AHFS Class | Change Date | Change Description |
